{"id":"W2303647913","doi":"10.1093/annonc/mdu337.32","title":"Phase Ii Study of Individualized Sunitinib As First-Line Therapy for Metastatic Clear Cell Renal Cell Cancer (Mrcc)","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame; Regional Municipality of Durham; BC Cancer Agency; Ottawa Hospital; Ozmosis Research (Canada); Queen Elizabeth II Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Sunitinib; Oncology; Renal cell carcinoma; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009146546,0.001399332,0.003035769,0.0005508434,0.0006268746,0.001130491,0.001064285,0.001323413,0.004755561],"category_scores_gemma":[0.0005468876,0.0006350877,0.001446556,0.000443913,0.0009409586,0.0009069338,0.0003286353,0.003400209,0.0009709603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00132305,"about_ca_system_score_gemma":0.002342429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002045903,"about_ca_topic_score_gemma":0.006251402,"domain_scores_codex":[0.9997025,0.00008673231,0.0000120957,0.00007761818,0.00002653058,0.00009445496],"domain_scores_gemma":[0.9994728,0.00005391133,0.00007467949,0.00004938956,0.00002958388,0.0003196428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7325945,0.09524085,0.005642849,0.0009428991,0.002038676,0.0002696785,0.0003840151,0.006668297,0.03894647,0.0004788361,0.005226559,0.1115664],"study_design_scores_gemma":[0.4922989,0.4848463,0.01191519,0.00003305292,0.0006255026,0.0003250114,0.0001021577,0.002371149,0.004703093,0.0002732821,0.002456252,0.00005018525],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940109,0.001483677,0.0004336057,0.0003079661,0.000134503,0.001428597,0.0006719937,0.0001159581,0.001412878],"genre_scores_gemma":[0.991684,0.001137848,0.001320277,0.0004237962,0.0001007583,0.001366551,0.001404594,0.00003675818,0.002525453],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004755561,"threshold_uncertainty_score":0.0159089,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1760285815499964,"score_gpt":0.4470818414900797,"score_spread":0.2710532599400832,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}